A portable molecular test, MiniDock MTB, detected pulmonary tuberculosis rapidly and accurately across seven high-burden countries, using sputum or tongue swab samples. The study suggests the low-cost, battery-operated platform could expand near-point-of-care TB diagnosis in low-resource settings, although real-world implementation and drug-resistance integration still need evaluation.